Addington, J and Addington, D (1993) Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia. Journal of Psychiatry and Neuroscience 18, 18.
Akaike, H. (1992). Information theory and an extension of the maximum likelihood principle. In Breakthroughs in statistics. Springer, New York, NY, pp. 610–624.
Albus, M, Hubmann, W, Scherer, J, Dreikorn, B, Hecht, S, Sobizack, N and Mohr, F (2002) A prospective 2-year follow-up study of neurocognitive functioning in patients with first-episode schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 252, 262–267.
Aleman, A, Hijman, R, de Haan, EH and Kahn, RS (1999) Memory impairment in schizophrenia: a meta-analysis. American Journal of Psychiatry 156, 1358–1366.
Benedetti, A and Abrahamowicz, M (2004) Using generalized additive models to reduce residual confounding. Statistics in Medicine 23, 3781–3801.
Benjamini, Y and Yekutieli, D (2001) The control of the false discovery rate in multiple testing under dependency. Annals of Statistics 29, 1165–1188.
Bilder, RM, Lipschutz-Broch, L, Reiter, G, Geisler, SH, Mayerhoff, DI and Lieberman, JA (1992) Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. Schizophrenia Bulletin 18, 437.
Bonner-Jackson, A, Grossman, LS, Harrow, M and Rosen, C (2010) Neurocognition in schizophrenia: a 20-year multi-follow-up of the course of processing speed and stored knowledge. Comprehensive Psychiatry 51, 471–479.
Bora, E, Yucel, M and Pantelis, C (2009) Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study. British Journal of Psychiatry 195, 475–482.
Bozikas, VP and Andreou, C (2011) Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature. Australian and New Zealand Journal of Psychiatry 45, 93–108.
Brissos, S, Dias, VV, Balanza-Martinez, V, Carita, AI and Figueira, ML (2011) Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance. Schizophrenia Research 129, 133–136.
Buckley, PF, Miller, BJ, Lehrer, DS and Castle, DJ (2008) Psychiatric comorbidities and schizophrenia. Schizophrenia Bulletin 35, 383–402.
Burdick, KE, Goldberg, JF, Harrow, M, Faull, RN and Malhotra, AK (2006) Neurocognition as a stable endophenotype in bipolar disorder and schizophrenia. The Journal of Nervous and Mental Disease 194, 255–260.
Buuren, SV and Fredriks, M (2001) Worm plot: a simple diagnostic device for modelling growth reference curves. Statistics in Medicine 20, 1259–1277.
Cassano, GB, Pini, S, Saettoni, M, Rucci, P and Dell'Osso, L (1998) Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders. The Journal of Clinical Psychiatry 59, 60–68.
Chen, EY, Lam, L, Chen, R, Nguyen, D and Chan, C (1996) Prefrontal neuropsychological impairment and illness duration in schizophrenia: a study of 204 patients in Hong Kong. Acta Psychiatrica Scandinavica 93, 144–150.
Cohen, J (1992) A power primer. Psychological Bulletin 112, 155.
Czaja, SJ, Charness, N, Fisk, AD, Hertzog, C, Nair, SN, Rogers, WA and Sharit, J (2006) Factors predicting the use of technology: findings from the Center for Research and Education on Aging and Technology Enhancement (CREATE). Psychology and Aging 21, 333–352.
D'Souza, MS and Markou, A (2012) Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits. Neuropharmacology 62, 1564–1573.
Davidson, M, Harvey, PD, Powchik, P and Parrella, M (1995) Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. The American journal of psychiatry 152, 197.
Davidson, M, Reichenberg, A, Rabinowitz, J, Weiser, M, Kaplan, Z and Mark, M (1999) Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. American Journal of Psychiatry 156, 1328–1335.
Deary, IJ, Corley, J, Gow, AJ, Harris, SE, Houlihan, LM, Marioni, RE, Penke, L, Rafnsson, SB and Starr, JM (2009) Age-associated cognitive decline. British medical bulletin 92, 135–152.
Fett, AK, Viechtbauer, W, Dominguez, MD, Penn, DL, van Os, J and Krabbendam, L (2011) The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neuroscience & Biobehavioral Reviews 35, 573–588.
Fioravanti, M, Carlone, O, Vitale, B, Cinti, ME and Clare, L (2005) A meta-analysis of cognitive deficits in adults with a diagnosis of schizophrenia. Neuropsychology Review 15, 73–95.
First, MB, Spitzer, RL, Gibbon, M and Williams, JB (2002) Structured clinical interview for DSM-IV-TR axis I disorders, research version Patient Edition. SCID-I/P.
Fleming, SK, Blasey, C and Schatzberg, AF (2004) Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis. Journal of Psychiatric Research 38, 27–35.
Friedman, JI, Harvey, PD, Coleman, T, Moriarty, PJ, Bowie, C, Parrella, M, White, L, Adler, D and Davis, KL (2001) Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. American Journal of Psychiatry 158, 1441–1448.
Fucetola, R, Seidman, LJ, Kremen, WS, Faraone, SV, Goldstein, JM and Tsuang, MT (2000) Age and neuropsychologic function in schizophrenia: a decline in executive abilities beyond that observed in healthy volunteers. Biological Psychiatry 48, 137–146.
Gallego, JA, Bonetti, J, Zhang, J, Kane, JM and Correll, CU (2012) Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009. Schizophrenia Research 138, 18–28.
Glahn, DC, Bearden, CE, Cakir, S, Barrett, JA, Najt, P, Serap Monkul, E, Maples, N, Velligan, DI and Soares, JC (2006) Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis. Bipolar Disorders 8, 117–123.
Glahn, DC, Bearden, CE, Barguil, M, Barrett, J, Reichenberg, A, Bowden, CL, Soares, JC and Velligan, DI (2007) The neurocognitive signature of psychotic bipolar disorder. Biological Psychiatry 62, 910–916.
Gooding, DC and Tallent, KA (2002) Spatial working memory performance in patients with schizoaffective psychosis versus schizophrenia: a tale of two disorders? Schizophrenia Research 53, 209–218.
Green, MF, Kern, RS, Braff, DL and Mintz, J (2000) Neurocognitive deficits and functional outcome in schizophrenia. Schizophrenia Bulletin 26, 119–136.
Gur, RE, Cowell, P, Turetsky, BI, Gallacher, F, Cannon, T, Bilker, W and Gur, RC (1998) A follow-up magnetic resonance imaging study of schizophrenia: relationship of neuroanatomical changes to clinical and neurobehavioral measures. Archives of General Psychiatry 55, 145–152.
Gur, RC, Calkins, ME, Satterthwaite, TD, Ruparel, K, Bilker, WB, Moore, TM, Savitt, AP, Hakonarson, H and Gur, RE (2014) Neurocognitive growth charting in psychosis spectrum youths. JAMA Psychiatry 71, 366–374.
Hall, RC (1995) Global assessment of functioning: a modified scale. Psychosomatics 36, 267–275.
Hartshorne, JK and Germine, LT (2015) When does cognitive functioning peak? The asynchronous rise and fall of different cognitive abilities across the life span. Psychological Science 26, 433–443.
Harvey, PD, Silverman, JM, Mohs, RC, Parrella, M, White, L, Powchik, P, Davidson, M and Davis, KL (1999) Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients. Biological Psychiatry 45, 32–40.
Heilbronner, U, Samara, M, Leucht, S, Falkai, P and Schulze, TG (2016) The longitudinal course of schizophrenia across the lifespan: clinical, cognitive, and neurobiological aspects. Harvard Review of Psychiatry 24, 118–128.
Hill, SK, Schuepbach, D, Herbener, ES, Keshavan, MS and Sweeney, JA (2004) Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naıve patients with schizophrenia. Schizophrenia Research 68, 49–63.
Hyde, TM, Nawroz, S, Goldberg, TE, Bigelow, LB, Strong, D, Ostrem, JL, Weinberger, DR and Kleinman, JE (1994) Is there cognitive decline in schizophrenia? A cross-sectional study. The British Journal of Psychiatry 164, 494–500.
Jones, P, Murray, R, Jones, P, Rodgers, B and Marmot, M (1994) Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. The Lancet 344, 1398–1402.
Levinson, DF, Mowry, BJ, Escamilla, MA and Faraone, SV (2002) The Lifetime Dimensions of Psychosis Scale (LDPS): description and interrater reliability. Schizophrenia Bulletin 28, 683–695.
Lin, X and Zhang, D (1999) Inference in generalized additive mixed models by using smoothing splines. Journal of the Royal Statistical Society: Series B (Statistical Methodology) 61, 381–400.
Løberg, E-M and Hugdahl, K (2009) Cannabis use and cognition in schizophrenia. Frontiers in Human Neuroscience 3, 53–61.
MacCabe, JH, Wicks, S, Lofving, S, David, AS, Berndtsson, A, Gustafsson, JE, Allebeck, P and Dalman, C (2013) Decline in cognitive performance between ages 13 and 18 years and the risk for psychosis in adulthood: a Swedish longitudinal cohort study in males. JAMA Psychiatry 70, 261–270.
Mathias, SR, Knowles, EEM, Barrett, J, Leach, O, Buccheri, S, Beetham, T, Blangero, J, Poldrack, RA and Glahn, DC (2017) The processing-speed impairment in psychosis is more than just accelerated aging. Schizophrenia Bulletin 43, 814–823.
Mathias, SR, Knowles, EEM, Barrett, J, Beetham, T, Leach, O, Buccheri, S, Aberizk, K, Blangero, J, Poldrack, RA and Glahn, DC (2018) Deficits in visual working-memory capacity and general cognition in African Americans with psychosis. Schizophrenia Research 193, 100–106.
McGurk, SR, Mueser, KT, DeRosa, TJ and Wolfe, R (2009) Work, recovery, and comorbidity in schizophrenia: a randomized controlled trial of cognitive remediation. Schizophrenia Bulletin 35, 319–335.
Meier, MH, Caspi, A, Reichenberg, A, Keefe, RS, Fisher, HL, Harrington, H, Houts, R, Poulton, R and Moffitt, TE (2013) Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study. American Journal of Psychiatry 171, 91–101.
Mockler, D, Riordan, J and Sharma, T (1997) Memory and intellectual deficits do not decline with age in schizophrenia. Schizophrenia Research 26, 1–7.
Mohamed, S, Paulsen, JS, O'leary, D, Arndt, S and Andreasen, N (1999) Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Archives of General Psychiatry 56, 749–754.
Mojtabai, R, Bromet, EJ, Harvey, PD, Carlson, GA, Craig, TJ and Fennig, S (2000) Neuropsychological differences between first-admission schizophrenia and psychotic affective disorders. American Journal of Psychiatry 157, 1453–1460.
Mollon, J, David, AS, Zammit, S, Lewis, G and Reichenberg, A (2018) Course of cognitive development from infancy to early adulthood in the psychosis spectrum. JAMA Psychiatry 75, 270–279.
Mueser, KT, Bellack, AS and Blanchard, JJ (1992) Comorbidity of schizophrenia and substance abuse: Implications for treatment. Journal of Consulting and Clinical Psychology 60, 845.
O'Leary, DS, Flaum, M, Kesler, ML, Flashman, LA, Arndt, S and Andreasen, NC (2000) Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia. The Journal of Neuropsychiatry and Clinical Neurosciences 12, 4–15.
Pencer, A and Addington, J (2003) Substance use and cognition in early psychosis. Journal of Psychiatry and Neuroscience 28, 48.
Pirkola, T, Tuulio-Henriksson, A, Glahn, D, Kieseppa, T, Haukka, J, Kaprio, J, Lonnqvist, J and Cannon, TD (2005) Spatial working memory function in twins with schizophrenia and bipolar disorder. Biological Psychiatry 58, 930–936.
R Development Core Team (2008) R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
Rajji, TK and Mulsant, BH (2008) Nature and course of cognitive function in late-life schizophrenia: a systematic review. Schizophrenia Research 102, 122–140.
Reichenberg, A and Harvey, PD (2007) Neuropsychological impairments in schizophrenia: integration of performance-based and brain imaging findings. Psychological Bulletin 133, 833–858.
Reichenberg, A, Harvey, PD, Bowie, CR, Mojtabai, R, Rabinowitz, J, Heaton, RK and Bromet, E (2009) Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophrenia Bulletin 35, 1022–1029.
Salthouse, T. A. (2009). When does age-related cognitive decline begin? Neurobiology of Aging 30, 507–514.
Samamé, C, Martino, DJ and Strejilevich, SA (2014) Longitudinal course of cognitive deficits in bipolar disorder: a meta-analytic study. Journal of Affective Disorders 164, 130–138.
Schatzberg, AF, Posener, JA, DeBattista, C, Kalehzan, BM, Rothschild, AJ and Shear, PK (2000) Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness. American Journal of Psychiatry 157, 1095–1100.
Schwarz, G (1978) Estimating the dimension of a model. The Annals of Statistics 6, 461–464.
Seidman, LJ, Buka, SL, Goldstein, JM and Tsuang, MT (2006) Intellectual decline in schizophrenia: evidence from a prospective birth cohort 28 year follow-up study. Journal of Clinical and Experimental Neuropsychology 28, 225–242.
Siman-Tov, T, Bosak, N, Sprecher, E, Paz, R, Eran, A, Aharon-Peretz, J and Kahn, I (2016) Early age-related functional connectivity decline in high-order cognitive networks. Frontiers in Aging Neuroscience 8, 330.
Singh-Manoux, A, Kivimaki, M, Glymour, MM, Elbaz, A, Berr, C, Ebmeier, KP, Ferrie, JE and Dugravot, A (2012) Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ 344, d7622.
Smith, PL (1979) Splines as a useful and convenient statistical tool. The American Statistician 33, 57–62.
Stahl, S and Grady, M (2004) A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation. Current Medicinal Chemistry 11, 313–327.
Szöke, A, Trandafir, A, Dupont, M-E, Méary, A, Schürhoff, F and Leboyer, M (2008) Longitudinal studies of cognition in schizophrenia: meta-analysis. The British Journal of Psychiatry 192, 248–257.
Vorstman, JA, Breetvelt, EJ, Duijff, SN, Eliez, S, Schneider, M, Jalbrzikowski, M, Armando, M, Vicari, S, Shashi, V, Hooper, SR, Chow, EW, Fung, WL, Butcher, NJ, Young, DA, McDonald-McGinn, DM, Vogels, A, van Amelsvoort, T, Gothelf, D, Weinberger, R, Weizman, A, Klaassen, PW, Koops, S, Kates, WR, Antshel, KM, Simon, TJ, Ousley, OY, Swillen, A, Gur, RE, Bearden, CE, Kahn, RS and Bassett, AS and for the International Consortium on, B. & Behavior in 22q11.2 Deletion, S (2015) Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome. JAMA Psychiatry 72, 377–385.
Yucel, M, Bora, E, Lubman, DI, Solowij, N, Brewer, WJ, Cotton, SM, Conus, P, Takagi, MJ, Fornito, A, Wood, SJ, McGorry, PD and Pantelis, C (2012) The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia Bulletin 38, 316–330.
Zanelli, J, Reichenberg, A, Morgan, K, Fearon, P, Kravariti, E, Dazzan, P, Morgan, C, Zanelli, C, Demjaha, A and Jones, PB (2010) Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations. American Journal of Psychiatry 167, 78–85.